[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Montelukast Intermediate Market, Global Outlook and Forecast 2022-2028

March 2022 | 77 pages | ID: MCC983A88E8DEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Montelukast Intermediate is a leukotriene receptor antagonist (LTRA)

This report contains market size and forecasts of Montelukast Intermediate in global, including the following market information:

Global Montelukast Intermediate Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Montelukast Intermediate Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Montelukast Intermediate companies in 2021 (%)

The global Montelukast Intermediate market was valued at 5143.4 million in 2021 and is projected to reach US$ 6069.2 million by 2028, at a CAGR of 2.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

GMP Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Montelukast Intermediate include VIVAN Life Sciences, P.G. Shah & Co., Manus Aktteva Biopharma and Ortin Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Montelukast Intermediate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Montelukast Intermediate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Montelukast Intermediate Market Segment Percentages, by Type, 2021 (%)
  • GMP
  • Non-GMP
Global Montelukast Intermediate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Montelukast Intermediate Market Segment Percentages, by Application, 2021 (%)
  • Asthma
  • Allergic Rhinitis
  • Bronchospasm
  • Urticaria
Global Montelukast Intermediate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Montelukast Intermediate Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Montelukast Intermediate revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Montelukast Intermediate revenues share in global market, 2021 (%)

Key companies Montelukast Intermediate sales in global market, 2017-2022 (Estimated), (MT)

Key companies Montelukast Intermediate sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • VIVAN Life Sciences
  • P.G. Shah & Co.
  • Manus Aktteva Biopharma
  • Ortin Laboratories
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Montelukast Intermediate Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Montelukast Intermediate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MONTELUKAST INTERMEDIATE OVERALL MARKET SIZE

2.1 Global Montelukast Intermediate Market Size: 2021 VS 2028
2.2 Global Montelukast Intermediate Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Montelukast Intermediate Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Montelukast Intermediate Players in Global Market
3.2 Top Global Montelukast Intermediate Companies Ranked by Revenue
3.3 Global Montelukast Intermediate Revenue by Companies
3.4 Global Montelukast Intermediate Sales by Companies
3.5 Global Montelukast Intermediate Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Montelukast Intermediate Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Montelukast Intermediate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Montelukast Intermediate Players in Global Market
  3.8.1 List of Global Tier 1 Montelukast Intermediate Companies
  3.8.2 List of Global Tier 2 and Tier 3 Montelukast Intermediate Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Montelukast Intermediate Market Size Markets, 2021 & 2028
  4.1.2 GMP
  4.1.3 Non-GMP
4.2 By Type - Global Montelukast Intermediate Revenue & Forecasts
  4.2.1 By Type - Global Montelukast Intermediate Revenue, 2017-2022
  4.2.2 By Type - Global Montelukast Intermediate Revenue, 2023-2028
  4.2.3 By Type - Global Montelukast Intermediate Revenue Market Share, 2017-2028
4.3 By Type - Global Montelukast Intermediate Sales & Forecasts
  4.3.1 By Type - Global Montelukast Intermediate Sales, 2017-2022
  4.3.2 By Type - Global Montelukast Intermediate Sales, 2023-2028
  4.3.3 By Type - Global Montelukast Intermediate Sales Market Share, 2017-2028
4.4 By Type - Global Montelukast Intermediate Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Montelukast Intermediate Market Size, 2021 & 2028
  5.1.2 Asthma
  5.1.3 Allergic Rhinitis
  5.1.4 Bronchospasm
  5.1.5 Urticaria
5.2 By Application - Global Montelukast Intermediate Revenue & Forecasts
  5.2.1 By Application - Global Montelukast Intermediate Revenue, 2017-2022
  5.2.2 By Application - Global Montelukast Intermediate Revenue, 2023-2028
  5.2.3 By Application - Global Montelukast Intermediate Revenue Market Share, 2017-2028
5.3 By Application - Global Montelukast Intermediate Sales & Forecasts
  5.3.1 By Application - Global Montelukast Intermediate Sales, 2017-2022
  5.3.2 By Application - Global Montelukast Intermediate Sales, 2023-2028
  5.3.3 By Application - Global Montelukast Intermediate Sales Market Share, 2017-2028
5.4 By Application - Global Montelukast Intermediate Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Montelukast Intermediate Market Size, 2021 & 2028
6.2 By Region - Global Montelukast Intermediate Revenue & Forecasts
  6.2.1 By Region - Global Montelukast Intermediate Revenue, 2017-2022
  6.2.2 By Region - Global Montelukast Intermediate Revenue, 2023-2028
  6.2.3 By Region - Global Montelukast Intermediate Revenue Market Share, 2017-2028
6.3 By Region - Global Montelukast Intermediate Sales & Forecasts
  6.3.1 By Region - Global Montelukast Intermediate Sales, 2017-2022
  6.3.2 By Region - Global Montelukast Intermediate Sales, 2023-2028
  6.3.3 By Region - Global Montelukast Intermediate Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Montelukast Intermediate Revenue, 2017-2028
  6.4.2 By Country - North America Montelukast Intermediate Sales, 2017-2028
  6.4.3 US Montelukast Intermediate Market Size, 2017-2028
  6.4.4 Canada Montelukast Intermediate Market Size, 2017-2028
  6.4.5 Mexico Montelukast Intermediate Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Montelukast Intermediate Revenue, 2017-2028
  6.5.2 By Country - Europe Montelukast Intermediate Sales, 2017-2028
  6.5.3 Germany Montelukast Intermediate Market Size, 2017-2028
  6.5.4 France Montelukast Intermediate Market Size, 2017-2028
  6.5.5 U.K. Montelukast Intermediate Market Size, 2017-2028
  6.5.6 Italy Montelukast Intermediate Market Size, 2017-2028
  6.5.7 Russia Montelukast Intermediate Market Size, 2017-2028
  6.5.8 Nordic Countries Montelukast Intermediate Market Size, 2017-2028
  6.5.9 Benelux Montelukast Intermediate Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Montelukast Intermediate Revenue, 2017-2028
  6.6.2 By Region - Asia Montelukast Intermediate Sales, 2017-2028
  6.6.3 China Montelukast Intermediate Market Size, 2017-2028
  6.6.4 Japan Montelukast Intermediate Market Size, 2017-2028
  6.6.5 South Korea Montelukast Intermediate Market Size, 2017-2028
  6.6.6 Southeast Asia Montelukast Intermediate Market Size, 2017-2028
  6.6.7 India Montelukast Intermediate Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Montelukast Intermediate Revenue, 2017-2028
  6.7.2 By Country - South America Montelukast Intermediate Sales, 2017-2028
  6.7.3 Brazil Montelukast Intermediate Market Size, 2017-2028
  6.7.4 Argentina Montelukast Intermediate Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Montelukast Intermediate Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Montelukast Intermediate Sales, 2017-2028
  6.8.3 Turkey Montelukast Intermediate Market Size, 2017-2028
  6.8.4 Israel Montelukast Intermediate Market Size, 2017-2028
  6.8.5 Saudi Arabia Montelukast Intermediate Market Size, 2017-2028
  6.8.6 UAE Montelukast Intermediate Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 VIVAN Life Sciences
  7.1.1 VIVAN Life Sciences Corporate Summary
  7.1.2 VIVAN Life Sciences Business Overview
  7.1.3 VIVAN Life Sciences Montelukast Intermediate Major Product Offerings
  7.1.4 VIVAN Life Sciences Montelukast Intermediate Sales and Revenue in Global (2017-2022)
  7.1.5 VIVAN Life Sciences Key News
7.2 P.G. Shah & Co.
  7.2.1 P.G. Shah & Co. Corporate Summary
  7.2.2 P.G. Shah & Co. Business Overview
  7.2.3 P.G. Shah & Co. Montelukast Intermediate Major Product Offerings
  7.2.4 P.G. Shah & Co. Montelukast Intermediate Sales and Revenue in Global (2017-2022)
  7.2.5 P.G. Shah & Co. Key News
7.3 Manus Aktteva Biopharma
  7.3.1 Manus Aktteva Biopharma Corporate Summary
  7.3.2 Manus Aktteva Biopharma Business Overview
  7.3.3 Manus Aktteva Biopharma Montelukast Intermediate Major Product Offerings
  7.3.4 Manus Aktteva Biopharma Montelukast Intermediate Sales and Revenue in Global (2017-2022)
  7.3.5 Manus Aktteva Biopharma Key News
7.4 Ortin Laboratories
  7.4.1 Ortin Laboratories Corporate Summary
  7.4.2 Ortin Laboratories Business Overview
  7.4.3 Ortin Laboratories Montelukast Intermediate Major Product Offerings
  7.4.4 Ortin Laboratories Montelukast Intermediate Sales and Revenue in Global (2017-2022)
  7.4.5 Ortin Laboratories Key News

8 GLOBAL MONTELUKAST INTERMEDIATE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Montelukast Intermediate Production Capacity, 2017-2028
8.2 Montelukast Intermediate Production Capacity of Key Manufacturers in Global Market
8.3 Global Montelukast Intermediate Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 MONTELUKAST INTERMEDIATE SUPPLY CHAIN ANALYSIS

10.1 Montelukast Intermediate Industry Value Chain
10.2 Montelukast Intermediate Upstream Market
10.3 Montelukast Intermediate Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Montelukast Intermediate Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Montelukast Intermediate in Global Market
Table 2. Top Montelukast Intermediate Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Montelukast Intermediate Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Montelukast Intermediate Revenue Share by Companies, 2017-2022
Table 5. Global Montelukast Intermediate Sales by Companies, (MT), 2017-2022
Table 6. Global Montelukast Intermediate Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Montelukast Intermediate Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Montelukast Intermediate Product Type
Table 9. List of Global Tier 1 Montelukast Intermediate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Montelukast Intermediate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Montelukast Intermediate Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Montelukast Intermediate Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Montelukast Intermediate Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Montelukast Intermediate Sales (MT), 2017-2022
Table 15. By Type - Global Montelukast Intermediate Sales (MT), 2023-2028
Table 16. By Application – Global Montelukast Intermediate Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Montelukast Intermediate Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Montelukast Intermediate Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Montelukast Intermediate Sales (MT), 2017-2022
Table 20. By Application - Global Montelukast Intermediate Sales (MT), 2023-2028
Table 21. By Region – Global Montelukast Intermediate Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Montelukast Intermediate Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Montelukast Intermediate Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Montelukast Intermediate Sales (MT), 2017-2022
Table 25. By Region - Global Montelukast Intermediate Sales (MT), 2023-2028
Table 26. By Country - North America Montelukast Intermediate Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Montelukast Intermediate Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Montelukast Intermediate Sales, (MT), 2017-2022
Table 29. By Country - North America Montelukast Intermediate Sales, (MT), 2023-2028
Table 30. By Country - Europe Montelukast Intermediate Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Montelukast Intermediate Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Montelukast Intermediate Sales, (MT), 2017-2022
Table 33. By Country - Europe Montelukast Intermediate Sales, (MT), 2023-2028
Table 34. By Region - Asia Montelukast Intermediate Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Montelukast Intermediate Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Montelukast Intermediate Sales, (MT), 2017-2022
Table 37. By Region - Asia Montelukast Intermediate Sales, (MT), 2023-2028
Table 38. By Country - South America Montelukast Intermediate Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Montelukast Intermediate Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Montelukast Intermediate Sales, (MT), 2017-2022
Table 41. By Country - South America Montelukast Intermediate Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Montelukast Intermediate Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Montelukast Intermediate Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Montelukast Intermediate Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Montelukast Intermediate Sales, (MT), 2023-2028
Table 46. VIVAN Life Sciences Corporate Summary
Table 47. VIVAN Life Sciences Montelukast Intermediate Product Offerings
Table 48. VIVAN Life Sciences Montelukast Intermediate Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. P.G. Shah & Co. Corporate Summary
Table 50. P.G. Shah & Co. Montelukast Intermediate Product Offerings
Table 51. P.G. Shah & Co. Montelukast Intermediate Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Manus Aktteva Biopharma Corporate Summary
Table 53. Manus Aktteva Biopharma Montelukast Intermediate Product Offerings
Table 54. Manus Aktteva Biopharma Montelukast Intermediate Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Ortin Laboratories Corporate Summary
Table 56. Ortin Laboratories Montelukast Intermediate Product Offerings
Table 57. Ortin Laboratories Montelukast Intermediate Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Montelukast Intermediate Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 59. Global Montelukast Intermediate Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Montelukast Intermediate Production by Region, 2017-2022 (MT)
Table 61. Global Montelukast Intermediate Production by Region, 2023-2028 (MT)
Table 62. Montelukast Intermediate Market Opportunities & Trends in Global Market
Table 63. Montelukast Intermediate Market Drivers in Global Market
Table 64. Montelukast Intermediate Market Restraints in Global Market
Table 65. Montelukast Intermediate Raw Materials
Table 66. Montelukast Intermediate Raw Materials Suppliers in Global Market
Table 67. Typical Montelukast Intermediate Downstream
Table 68. Montelukast Intermediate Downstream Clients in Global Market
Table 69. Montelukast Intermediate Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Montelukast Intermediate Segment by Type
Figure 2. Montelukast Intermediate Segment by Application
Figure 3. Global Montelukast Intermediate Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Montelukast Intermediate Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Montelukast Intermediate Revenue, 2017-2028 (US$, Mn)
Figure 7. Montelukast Intermediate Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Montelukast Intermediate Revenue in 2021
Figure 9. By Type - Global Montelukast Intermediate Sales Market Share, 2017-2028
Figure 10. By Type - Global Montelukast Intermediate Revenue Market Share, 2017-2028
Figure 11. By Type - Global Montelukast Intermediate Price (USD/MT), 2017-2028
Figure 12. By Application - Global Montelukast Intermediate Sales Market Share, 2017-2028
Figure 13. By Application - Global Montelukast Intermediate Revenue Market Share, 2017-2028
Figure 14. By Application - Global Montelukast Intermediate Price (USD/MT), 2017-2028
Figure 15. By Region - Global Montelukast Intermediate Sales Market Share, 2017-2028
Figure 16. By Region - Global Montelukast Intermediate Revenue Market Share, 2017-2028
Figure 17. By Country - North America Montelukast Intermediate Revenue Market Share, 2017-2028
Figure 18. By Country - North America Montelukast Intermediate Sales Market Share, 2017-2028
Figure 19. US Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Montelukast Intermediate Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Montelukast Intermediate Sales Market Share, 2017-2028
Figure 24. Germany Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 25. France Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Montelukast Intermediate Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Montelukast Intermediate Sales Market Share, 2017-2028
Figure 33. China Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 37. India Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Montelukast Intermediate Revenue Market Share, 2017-2028
Figure 39. By Country - South America Montelukast Intermediate Sales Market Share, 2017-2028
Figure 40. Brazil Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Montelukast Intermediate Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Montelukast Intermediate Sales Market Share, 2017-2028
Figure 44. Turkey Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Montelukast Intermediate Revenue, (US$, Mn), 2017-2028
Figure 48. Global Montelukast Intermediate Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Montelukast Intermediate by Region, 2021 VS 2028
Figure 50. Montelukast Intermediate Industry Value Chain
Figure 51. Marketing Channels


More Publications